Loss of L-FABP, SCP-2/SCP-x, or both induces hepatic lipid accumulation in female mice

Archives of Biochemistry and Biophysics

Volumn 580, Issue , 2015, Pages 41-49

  Martin, Gregory G ^a   Atshaves, Barbara P ^b   Landrock, Kerstin K ^c   Landrock, Danilo ^c   Schroeder, Friedhelm ^a   Kier, Ann B ^c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b Michigan State University   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Gene ablation; L FABP; SCP 2; SCP x

Indexed keywords

ACYLTRANSFERASE; APOLIPOPROTEIN; APOLIPOPROTEIN B; CARRIER PROTEINS AND BINDING PROTEINS; CHOLESTEROL; FATTY ACID BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIVER FATTY ACID BINDING PROTEIN; LONG CHAIN FATTY ACID; LOW DENSITY LIPOPROTEIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL CARRIER PROTEIN 2; STEROL CARRIER PROTEIN X; UNCLASSIFIED DRUG; CARRIER PROTEIN; CHOLESTEROL ESTER; FABP1 PROTEIN, MOUSE; FATTY ACID; PHOSPHOLIPID; STEROL CARRIER PROTEINS; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASOLATERAL MEMBRANE; BILE SECRETION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ESTERIFICATION; FATTY ACID BLOOD LEVEL; FATTY ACID TRANSPORT; FEMALE; LIPID ANALYSIS; LIPID HOMEOSTASIS; LIPID LIVER LEVEL; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; LIVER HOMOGENATE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ANIMAL; BLOOD; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; GENE DELETION; GENE EXPRESSION; GENETICS; KNOCKOUT MOUSE; LIPID METABOLISM; LIVER; METABOLISM; PATHOLOGY;

ANIMALIA; MUS;

ANIMALS; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTERS; DISEASE MODELS, ANIMAL; FATTY ACID-BINDING PROTEINS; FATTY ACIDS, NONESTERIFIED; FEMALE; GENE DELETION; GENE EXPRESSION; LIPID METABOLISM; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NON-ALCOHOLIC FATTY LIVER DISEASE; PHOSPHOLIPIDS; TRIGLYCERIDES;

EID: 84935429502     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2015.06.009     Document Type: Article

References (109)

1. Y. Kawano, and D.E. Cohen Mechanisms of hepatic triglyceride accumulation in non-alcoholic liver disease J. Gastroenterol. 48 2013 434 441
2. K. Gariani, J. Philippe, and F.R. Jornayvaz Non-alcoholic liver disease and insulin resistance: from bench to bedside Diab. Metab. 39 2013 16 26
3. A. Tailleux, K. Wouters, and B. Staels Role of PPARs in NAFLD: potential therapeutic targets Biochim. Biophys. Acta 1821 2012 809 818
4. G. Paz-Filho, C.A. Mastronardi, B.J. Parker, A. Khan, A. Inserra, K.I. Matthaei, M. Erhart-Bornstein, S. Bornstein, M.-L. Wong, and J. Licinio Molecular pathways involved in the improvement of nonalcoholic fatty liver disease J. Mol. Endocrinol. 51 2013 167 179
5. A. Vluggens, and J.K. Reddy Nuclear receptors and transcription factors in the development of fatty liver disease Curr. Drug Metab. 13 2012 1422 1435
6. P. Puri, R.A. Baillie, M.M. Wiest, F. Mirshahi, J. Choudhury, O. Cheung, C. Sergeant, M.J. Contos, and A.J. Sanyal A lipidomic analysis of nonalcoholic fatty liver disease Hepatology 46 2007 1081 1090
7. A.P.L. Jensen-Urstad, and C.F. Emenkovich Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger? Biochim. Biophys. Acta 1821 2012 747 753
8. A.D. Quiroga, and R. Lehner Liver triacylglycerol lipases Biochim. Biophys. Acta 1821 2012 762 769
9. P. Puri, M.M. Wiest, O. Cheung, F. Mirshahi, C. Sargeant, H.-K. Min, M.J. Contos, R.K. Sterling, M. Fuchs, H. Zhou, S.M. Watkins, and A.J. Sanyal The plasma lipidomic signature of nonalcoholic steatohepatitis Hepatology 50 2009 1827 1838
10. X.-E. Peng, Y.L. Wu, Q.-Q. Lu, Z.-J. Ju, and X. Lin Two genetic variants in FABP1 and susceptibility to non-alcoholic fatty liver disease in a Chinese population Gene 500 2012 54 58
11. A.L. McIntosh, H. Huang, S.M. Storey, K. Landrock, D. Landrock, A.D. Petrescu, S. Gupta, B.P. Atshaves, A.B. Kier, and F. Schroeder Human FABP1 T94A variant impacts fatty acid metabolism and PPARa activation in cultured human female hepatocytes Am. J. Physiol. Gastrointest. Liver Phys. 307 2014 G164 G176
12. A.E. Feldstein, N.W. Werneburg, and A. Canbay Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway Hepatology 40 2004 185 194
13. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis summary of an AASLD single topic conference Hepatology 37 2003 1202 1219
14. A.M. Gallegos, B.P. Atshaves, S.M. Storey, O. Starodub, A.D. Petrescu, H. Huang, A. McIntosh, G. Martin, H. Chao, A.B. Kier, and F. Schroeder Gene structure, intracellular localization, and functional roles of sterol carrier protein-2 Prog. Lipid Res. 40 2001 498 563
15. S.M. Colles, J.K. Woodford, D. Moncecchi, S.C. Myers-Payne, L.R. McLean, J.T. Billheimer, and F. Schroeder Cholesterol interactions with recombinant human sterol carrier protein-2 Lipids 30 1995 795 804
16. G.G. Martin, B.P. Atshaves, H. Huang, A.L. McIntosh, B.W. Williams, P.-J. Pai, D.H. Russell, A.B. Kier, and F. Schroeder Hepatic phenotype of liver fatty acid binding protein (L-FABP) gene ablated mice Am. J. Physiol. 297 2009 G1053 G1065
17. G.G. Martin, B.P. Atshaves, K.K. Landrock, D. Landrock, S.M. Storey, P.N. Howles, A.B. Kier, and F. Schroeder Ablating L-FABP in SCP-2/SCP-x null mice impairs bile acid metabolism and biliary HDL-cholesterol secretion Am. J. Physiol. Gastrointest. Liver Phys. 307 2014 G1130 G1143
18. H. Huang, A.L. McIntosh, G.G. Martin, K.K. Landrock, D. Landrock, S.M. Storey, S. Gupta, B.P. Atshaves, A.B. Kier, and F. Schroeder Human L-FABP T94A variant enhances cholesterol uptake Biochim. Biophys. Acta 1851 2015 946 955
19. A. Frolov, T.H. Cho, J.T. Billheimer, and F. Schroeder Sterol carrier protein-2, a new fatty acyl coenzyme A-binding protein J. Biol. Chem. 271 1996 31878 31884
20. T. Hubbell, W.D. Behnke, J.K. Woodford, and F. Schroeder Recombinant liver fatty acid binding protein interactions with fatty Acyl-Coenzyme A Biochemistry 33 1994 3327 3334
21. A. Frolov, T.H. Cho, E.J. Murphy, and F. Schroeder Isoforms of rat liver fatty acid binding protein differ in structure and affinity for fatty acids and fatty acyl CoAs Biochemistry 36 1997 6545 6555
22. H. Huang, A.L. McIntosh, G.G. Martin, K. Landrock, D. Landrock, S. Gupta, B.P. Atshaves, A.B. Kier, and F. Schroeder Structural and functional interaction of fatty acids with human liver fatty acid binding protein (L-FABP) T94A variant FEBS J. 281 2014 2266 2283
23. K.L. Gavey, B.J. Noland, and T.J. Scallen The participation of sterol carrier protein2 in the conversion of cholesterol to cholesterol ester by rat liver microsomes J. Biol. Chem. 256 1981 2993 2999
24. G. Nemecz, and F. Schroeder Selective binding of cholesterol by recombinant fatty acid-binding proteins J. Biol. Chem. 266 1991 17180 17186
25. H. Chao, J.T. Billheimer, A.B. Kier, and F. Schroeder Microsomal long chain fatty acyl CoA transacylation: differential effect of SCP-2 Biochim. Biophys. Acta 1439 1999 371 383
26. H. Chao, M. Zhou, A. McIntosh, F. Schroeder, and A.B. Kier Acyl CoA binding protein and cholesterol differentially alter fatty acyl CoA utilization by microsomal acyl CoA: cholesterol transferase J. Lipid Res. 44 2003 72 83
27. E.J. Murphy, and F. Schroeder Sterol carrier protein-2 mediated cholesterol esterification in transfected L-cell fibroblasts Biochim. Biophys. Acta 1345 1997 283 292
28. J.R. Jefferson, J.P. Slotte, G. Nemecz, A. Pastuszyn, T.J. Scallen, and F. Schroeder Intracellular sterol distribution in transfected mouse L-cell fibroblasts expressing rat liver fatty acid binding protein J. Biol. Chem. 266 1991 5486 5496
29. U. Bordewick, M. Heese, T. Borchers, H. Robenek, and F. Spener Compartmentation of hepatic fatty-acid-binding protein in liver cells and its effect on microsomal phosphatidic acid biosynthesis Biol. Chem. Hoppe-Seyler 370 1989 229 238
30. C.A. Jolly, T. Hubbell, W.D. Behnke, and F. Schroeder Fatty acid binding protein: stimulation of microsomal phosphatidic acid formation Arch. Biochem. Biophys. 341 1997 112 121
31. C.A. Jolly, E.J. Murphy, and F. Schroeder Differential influence of rat liver fatty acid binding protein isoforms on phospholipid fatty acid composition: phosphatidic acid biosynthesis and phospholipid fatty acid remodeling Biochim. Biophys. Acta 1390 1998 258 268
32. H.A. Hostetler, D. Lupas, Y. Tan, J. Dai, M.S. Kelzer, G.G. Martin, G. Woldegiorgis, A.B. Kier, and F. Schroeder Acyl-CoA binding proteins interact with the acyl-CoA binding domain of mitochondrial carnitine palmitoyltransferase I Mol. Cell. Biochem. 355 2011 135 148
33. S. Kawata, Y. Imai, M. Inada, M. Inui, H. Kakimoto, K. Fukuda, Y. Maeda, and S. Tarui Modulation of cholesterol 7-a hydroxylase activity by nsLTP in human liver - possible altered regulation of its cytosolic level in patients with gallstones Clin. Chim. Acta 197 1991 201 208
34. U. Seedorf, P. Brysch, T. Engel, K. Schrage, and G. Assmann Sterol carrier protein X is peroxisomal 3-oxoacyl coenzyme A thiolase with intrinsic sterol carrier and lipid transfer activity J. Biol. Chem. 269 1994 21277 21283
35. R.J.A. Wanders, S. Denis, F. Wouters, K.W.A. Wirtz, and U. Seedorf Sterol carrier Protein X (SCPx) is a peroxisomal branched-chain b-ketothiolase specifically reacting with 3-Oxo-pristanoyl-CoA: a new, unique role for SCPx in branched-chain fatty acid metabolism in peroxisomes Biochem. Biophys. Res. Commun. 236 1997 565 569
36. Q.M. Anstee, A.K. Daly, and C.P. Day Genetic modifiers of non-alcoholic fatty liver disease progression Biochim. Biophys. Acta 1812 2011 1557 1566
37. F. Schroeder, C.A. Jolly, T.H. Cho, and A.A. Frolov Fatty acid binding protein isoforms: structure and function Chem. Phys. Lipids 92 1998 1 25
38. R.E. Gossett, R.D. Edmondson, C.A. Jolly, T.H. Cho, D.H. Russell, J. Knudsen, A.B. Kier, and F. Schroeder Structure and function of normal and transformed murine acyl CoA binding proteins Arch. Biochem. Biophys. 350 1998 201 213
39. S. Mishkin, and R. Turcotte Stimulation of monoacylglycerophosphate formation by Z protein Biochem. Biophys. Res. Commun. 60 1974 376 381
40. D.A. Burnett, N. Lysenko, J.A. Manning, and R.K. Ockner Utilization of long chain fatty acids by rat liver: studies of the role of fatty acid binding protein Gastroenterology 77 1979 241 249
41. S.C. Jamdar Hepatic lipid metabolism: effect of spermine, albumin, and Z protein on microsomal lipid formation Arch. Biochem. Biophys. 195 1979 81 94
42. S.Y. Yang, X.Y. He, and H. Schulz Fatty acid oxidation in rat brain is limited by the low activity of 3-ketoacyl-coenzyme A thiolase J. Biol. Chem. 262 1987 13027 13032
43. N. Higuchi, M. Kato, and M. Tanaka Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP, and L-FABP in non-alcoholic fatty liver disease Exp. Ther. Med. 2 2011 1077 1081
44. M. Charlton, K. Viker, A. Krishnan, S. Sanderson, B. Veldt, A.J. Kaalsbeek, M. Kendrick, G. Thompson, F. Que, J. Swain, and M. Sarr Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease Hepatology 49 2009 1375 1384
45. J.N. Baumgardner, K. Shankar, L. Hennings, T.M. Badger, and M.J.J. Ronis A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet Am. J. Physiol. Gastrointest. Liver Phys. 294 2007 G27 G38
46. E.P. Newberry, Y. Xie, S. Kennedy, K.K. Buhman, J. Luo, R.W. Gross, and N.O. Davidson Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid binding protein gene J. Biol. Chem. 278 2003 51664 51672
47. E.P. Newberry, S.M. Kennedy, Y. Xie, B.T. Sternard, J. Luo, and N.O. Davidson Diet-induced obesity and hepatic steatosis in L-FABP-/- mice is abrogated with SF, but not PUFA, feeding and attenuated after cholesterol supplementation Am. J. Physiol. Gastrointest. Liver Phys. 294 2008 G307 G314
48. E.P. Newberry, S.M. Kennedy, Y. Xie, J. Luo, S.E. Stanley, C.F. Semenkovich, R.M. Crooke, M.J. Graham, and N.O. Davidson Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models Hepatology 48 2008 1097 1105
49. Y. Xie, E.P. Newberry, S.M. Kennedy, J. Luo, and N.O. Davidson Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice J. Lipid Res. 50 2009 977 987
50. A. Chen, Y. Tang, V. Davis, F.-F. Hsu, S.M. Kennedy, H. Song, J. Turk, E.M. Brunt, E.P. Newberry, and N.O. Davidson L-FABP modulates murine stellate cell activation and diet induced nonalcoholic fatty liver disease Hepatology 57 2013 2202 2212
51. C. Guzman, M. Benet, S. Pisonero-Vaquero, M. Moya, M.V. Garcia-Mediavilla, M.L. Martinez-Chantar, J. Gonzalez-Gallego, J.V. Castell, S. Sanchez-Campos, and R. Jover The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARa; and repressed by C/EBPa: implication in FABP1 down-regulation in nonalcoholic liver disease Biochim. Biophys. Acta 1831 2013 803 818
52. G. Rajaraman, G.Q. Wang, J. Yan, P. Jiang, Y. Gong, and F.J. Burczynski Role of cytosolic liver fatty acid binding protein in hepatocellular oxidative stress: effect of dexamethasone and clofibrate treatment Mol. Cell. Biochem. 295 2007 27 34
53. G. Wang, Y. Gong, J. Anderson, D. Sun, G. Minuk, M.S. Robertes, and F.J. Burczynski Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells Hepatology 42 2005 871 879
54. G. Wang, H. Shen, G. Rajaraman, M.S. Roberts, Y. Gong, P. Jiang, and F.J. Burczynski Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats Eur. J. Pharm. 560 2007 61 68
55. J. Yan, Y. Gong, Y.-M. She, G. Wang, M.S. Roberts, and F.J. Burczynski Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity J. Lipid Res. 50 2009 2445 2454
56. J. Yan, Y. Gong, Y.M. She, G. Wang, M.S. Robertes, and F.J. Burczynski Molecular mechanism of recombinant L-FABP's antioxidant activity J. Lipid Res. 50 2010 2445 2454
57. R.L. Smathers, K.S. Fritz, J.J. Galligan, C.T. Shearn, P. Reigan, M.J. Marks, and D.R. Petersen Characterization of 4-HNE modified L-FABP reveals alterations in structural and functional dynamics PPAR Res. 7 2012 e38459
58. W. Fan, K. Chen, G. Zheng, W. Wang, A. Teng, A. Liu, D. Ming, and P. Yan Role of liver fatty acid binding protein in hepatocellular injury: effect of CrPic treatment J. Inorg. Biochem. 124 2013 46 53
59. J. Robitaille, C. Brouillette, S. Lemieux, L. Perusse, D. Gaudet, and M.-C. Vohl Plasma concentrations of apolipoprotein B are modulated by a gene-diet interaction effect between the L-FABP T94A polymorphism and dietary fat intake in French-Canadian men Mol. Genet. Metab. 82 2004 296 303
60. E. Fisher, C. Weikert, M. Klapper, I. Lindner, M. Mohlig, J. Spranger, H. Boeing, J. Schrezenmeir, and F. Doring L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women Mol. Genet. Metab. 91 2007 278 284
61. M.O. Weikert, C.V. Loeffelholz, M. Roden, V. Chandramouli, A. Brehm, P. Nowotny, M.A. Osterhoff, F. Isken, J. Spranger, B.R. Landau, A. Pfeiffer, and M. Mohlig A Thr94Ala mutation in human liver fatty acid binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects Am. J. Physiol. Endocrinol. Metab. 293 2007 E1078 E1084
62. Y. Yamada, K. Kato, M. Oguri, T. Yoshida, K. Yokoi, S. Watanabe, N. Metoki, H. Yoshida, K. Satoh, S. Ichihara, Y. Aoyagi, A. Yasunaga, H. Park, M. Tanaka, and Y. Nozawa Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome Int. J. Mol. Med. 21 2008 801 808
63. L. Bu, L.M. Salto, K.J. De Leon, and M. De Leon Polymorphisms in fatty acid binding protein 5 show association with type 2 diabetes Diab. Res. Clin. Pract. 92 2011 82 91
64. M.L. Mansego, F. Martinez, M.T. Martinez-Larrad, C. Zabena, G. Rojo, S. Morcillo, F. Soriguer, J.C. Martin-Escudero, M. Serrano-Rios, J. Redon, and F.J. Chaves Common variants of the liver fatty acid binding protein gene influence the risk of Type 2 Diabetes and insulin resistance in Spanish population PLoS One 7 2012 e31853
65. M. Fuchs, A. Hafer, C. Muench, F. Kannenberg, S. Teichmann, J. Scheibner, E.F. Stange, and U. Seedorf Disruption of the sterol carrier protein 2 gene in mice impairs biliary lipid and hepatic cholesterol metabolism J. Biol. Chem. 276 2001 48058 48065
66. U. Seedorf, M. Raabe, P. Ellinghaus, F. Kannenberg, M. Fobker, T. Engel, S. Denis, F. Wouters, K.W.A. Wirtz, R.J.A. Wanders, N. Maeda, and G. Assmann Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function Genes Dev. 12 1998 1189 1201
67. B.P. Atshaves, A.L. McIntosh, D. Landrock, H.R. Payne, J. Mackie, N. Maeda, J.M. Ball, F. Schroeder, and A.B. Kier Effect of SCP-x gene ablation on branched-chain fatty acid metabolism Am. J. Physiol. 292 2007 939 951
68. B.P. Atshaves, A.L. McIntosh, G.G. Martin, D. Landrock, H.R. Payne, S. Bhuvanendran, K. Landrock, O.I. Lyuksyutova, J.D. Johnson, R.D. Macfarlane, A.B. Kier, and F. Schroeder Overexpression of sterol carrier protein-2 differentially alters hepatic cholesterol accumulation in cholesterol-fed mice J. Lipid Res. 50 2009 1429 1447
69. B.P. Atshaves, A. Petrescu, O. Starodub, J. Roths, A.B. Kier, and F. Schroeder Expression and intracellular processing of the 58 kDa sterol carrier protein 2/3-Oxoacyl-CoA thiolase in transfected mouse L-cell fibroblasts J. Lipid Res. 40 1999 610 622
70. C.A. Jolly, D.A. Wilton, and F. Schroeder Microsomal fatty acyl CoA transacylation and hydrolysis: fatty acyl CoA species dependent modulation by liver fatty acyl CoA binding proteins Biochim. Biophys. Acta 1483 2000 185 197
71. G.G. Martin, H. Danneberg, L.S. Kumar, B.P. Atshaves, E. Erol, M. Bader, F. Schroeder, and B. Binas Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid binding protein (L-FABP) gene J. Biol. Chem. 278 2003 21429 21438
72. B.P. Atshaves, A.L. McIntosh, H.R. Payne, A.M. Gallegos, K. Landrock, N. Maeda, A.B. Kier, and F. Schroeder Sterol carrier protein-2/sterol carrier protein-x gene ablation alters lipid raft domains in primary cultured mouse hepatocytes J. Lipid Res. 48 2007 2193 2211
73. S.M. Storey, B.P. Atshaves, A.L. McIntosh, K.K. Landrock, G.G. Martin, H. Huang, J.D. Johnson, R.D. Macfarlane, A.B. Kier, and F. Schroeder Effect of sterol carrier protein-2 gene ablation on HDL-mediated cholesterol efflux from primary cultured mouse hepatocytes Am. J. Physiol. 299 2010 244 254
74. J.E. Thigpen, K.D. Setchell, K.B. Ahlmark, J. Kocklear, T. Spahr, G.F. Caviness, M.F. Goelz, J.K. Haseman, R.R. Newbold, and D.B. Forsythe Phytoestrogen content of purified, open- and closed-formula laboratory animal diets Lab. Anim. Sci. 49 1999 530 536
75. J.E. Thigpen, K.D. Setchell, M.F. Goelz, and D.B. Forsythe The phytoestrogen content of rodent diets Environ. Health Perspect. 107 1999 A182 A183
76. A. Adida, and F. Spener Intracellular lipid binding proteins and nuclear receptors involved in branched-chain fatty acid signaling Prostaglandins Leukot. Essent. Fatty Acids 67 2002 91 98
77. P. Ellinghaus, C. Wolfrum, G. Assmann, F. Spener, and U. Seedorf Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARalpha) in sterol carrier protein-2-/sterol carrier protein x-deficient mice J. Biol. Chem. 274 1999 2766 2772
78. T. Hanhoff, S. Benjamin, T. Borchers, and F. Spener Branched-chain fatty acids as activators of peroxisome proliferators Eur. J. Lipid Sci. Technol. 107 2005 716 729
79. C. Wolfrum, P. Ellinghaus, M. Fobker, U. Seedorf, G. Assmann, T. Borchers, and F. Spener Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein J. Lipid Res. 40 1999 708 714
80. B.P. Atshaves, H.R. Payne, A.L. McIntosh, S.E. Tichy, D. Russell, A.B. Kier, and F. Schroeder Sexually dimorphic metabolism of branched chain lipids in C57BL/6J mice J. Lipid Res. 45 2004 812 830
81. B.P. Atshaves, S. Storey, A.L. McIntosh, A.D. Petrescu, O.I. Lyuksyutova, A.S. Greenberg, and F. Schroeder Sterol carrier protein-2 expression modulates protein and lipid composition of lipid droplets J. Biol. Chem. 276 2001 25324 25335
82. A. Marzo, P. Ghirardi, D. Sardini, and G. Meroni Simplified measurement of monoglycerides, diglycerides, triglycerides, and free fatty acids in biological samples Clin. Chem. 17 1971 145 147
83. E.J. Murphy, T. Stiles, and F. Schroeder Sterol carrier protein-2 expression alters phospholipid content and fatty acid composition in L-cell fibroblasts J. Lipid Res. 41 2000 788 796
84. B.P. Atshaves, A.L. McIntosh, O.I. Lyuksyutova, W.R. Zipfel, W.W. Webb, and F. Schroeder Liver fatty acid binding protein gene ablation inhibits branched-chain fatty acid metabolism in cultured primary hepatocytes J. Biol. Chem. 279 2004 30954 30965
85. A.L. McIntosh, B.P. Atshaves, H.A. Hostetler, H. Huang, J. Davis, O.I. Lyuksyutova, D. Landrock, A.B. Kier, and F. Schroeder Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator activated receptor-alpha activity in cultured primary hepatocytes Arch. Biochem. Biophys. 485 2009 160 173
86. O. Starodub, C.A. Jolly, B.P. Atshaves, J.B. Roths, E.J. Murphy, A.B. Kier, and F. Schroeder Sterol carrier protein-2 immunolocalization in endoplasmic reticulum and stimulation of phospholipid formation Am. J. Physiol. 279 2000 C1259 C1269
87. D.M. Moncecchi, G. Nemecz, F. Schroeder, and T.J. Scallen The participation of sterol carrier protein-2 (SCP-2) in cholesterol metabolism G.W. Patterson, W.D. Nes, Physiology and Biochemistry of Sterols 1991 American Oil Chemists' Society Press Champaign, IL 1 27
88. R. Sato, W. Miyamoto, J. Inoue, T. Terada, T. Imanaka, and M. Maeda SREBP negatively regulates MTTP gene transcription J. Biol. Chem. 274 1999 24714 24720
89. M.E. Hinsdale, P.M. Sullivan, H. Mezdour, and N. Maeda Apo B-48 and Apo B-100 differentially influence the expression of type-III hyperlipoproteinemia in apoE-2 mice Diabetes 43 2002 1520 1528
90. C.H. Wiegman, H.J. Bandsma, M. Ouwens, F.H. van der Sluijs, R. Havinga, T. Boes, D.-J. Reijngoud, J.A. Romjin, and F. Kuipers Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to suppressive effects of insulin Diabetes 52 2003 1081 1089
91. S. Ferdinandusse, P. Kostopoulos, S. Denis, R. Rusch, H. Overmars, U. Dillman, W. Reith, D. Haas, R.J.A. Wanders, M. Duran, and M. Marziniak Mutations in the gene encoding peroxisomal sterol carrier protein-x (SCP-x) cause leukoencephalopathy with dystonia and motor neuropathy Am. J. Hum. Genet. 78 2006 1046 1052
92. B.P. Atshaves, G.G. Martin, H.A. Hostetler, A.L. McIntosh, A.B. Kier, and F. Schroeder Liver fatty acid binding protein (L-FABP) and Dietary Obesity J. Nutr. Biochem. 21 2010 1015 1032
93. C. Brouillette, Y. Bose, L. Perusse, D. Gaudet, and M.-C. Vohl Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate J. Hum. Genet. 49 2004 424 432
94. Y. Tian, H. Li, S. Wang, J. Yan, Z. Chen, Z. Li, H. Feng, H. Zhou, and D. Ouyang Association of L-FABP T94A, MTP I128T polymorphisms and hyperlipidemia in Chinese subjects Lipids 50 2015 275 282
95. G.G. Martin, A.L. McIntosh, H. Huang, S. Gupta, B.P. Atshaves, A.B. Kier, and F. Schroeder Human liver fatty acid binding protein (L-FABP) T94A variant alters structure, stability, and interaction with fibrates Biochemistry 52 2013 9347 9357
96. A.A. Frolov, and F. Schroeder Acyl coenzyme A binding protein: conformational sensitivity to long chain fatty acyl-CoA J. Biol. Chem. 273 1998 11049 11055
97. H. Chao, F. Schroeder, and A.B. Kier Acyl CoA binding protein (ACBP) T.E. Creighton, Wiley Encyclopedia of Molecular Medicine 2002 J. Wiley & Sons Inc. New York, N.Y. 44 47
98. H. Chao, G. Martin, W.K. Russell, S.D. Waghela, D.H. Russell, F. Schroeder, and A.B. Kier Membrane charge and curvature determine interaction with acyl CoA binding protein (ACBP) and fatty acyl CoA targeting Biochemistry 41 2002 10540 10553
99. G.G. Martin, H.A. Hostetler, A.L. McIntosh, S.E. Tichy, B.J. Williams, D.H. Russell, J.M. Berg, T.A. Spencer, J.A. Ball, A.B. Kier, and F. Schroeder Structure and function of the sterol carrier protein-2 (SCP-2) N-terminal pre-sequence Biochemistry 47 2008 5915 5934
100. G.V. Richieri, R.T. Ogata, and A.M. Kleinfeld Equilibrium constants for the binding of fatty acids with fatty acid binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB J. Biol. Chem. 269 1994 23918 23930
101. B. Rolf, E. Oudenampsen-Kruger, T. Borchers, N.J. Faergeman, J. Knudsen, A. Lezius, and F. Spener Analysis of the ligand binding properties of recombinant bovine liver-type fatty acid binding protein Biochim. Biophys. Acta 1259 1995 245 253
102. L. Kannan, J. Knudsen, and C.A. Jolly Aging and acyl CoA binding protein alter mitochondrial glycerol-3-phosphate acyltransferase activity Biochim. Biophys. Acta 1631 2003 12 16
103. 13C-NMR investigation of cholesterol and fatty acid binding sites J. Biol. Chem. 274 1999 35425 35433
104. N.J. Stolowich, A.D. Petrescu, H. Huang, G. Martin, A.I. Scott, and F. Schroeder Sterol carrier protein-2: structure reveals function Cell. Mol. Life Sci. 59 2002 193 212
105. N.J. Stolowich, A. Frolov, B.P. Atshaves, E. Murphy, C.A. Jolly, J.T. Billheimer, A.I. Scott, and F. Schroeder The sterol carrier protein-2 fatty acid binding site: an NMR, Circular Dichroic, and Fluorescence spectroscopic determination Biochemistry 36 1997 1719 1729
106. F. Schroeder, A. Frolov, J. Schoer, A. Gallegos, B.P. Atshaves, N.J. Stolowich, A.I. Scott, and A.B. Kier Intracellular sterol binding proteins, cholesterol transport and membrane domains T.Y. Chang, D.A. Freeman, Intracellular Cholesterol Trafficking 1998 Kluwer Academic Publishers Boston 213 234
107. E.J. Murphy, D.R. Prows, J.R. Jefferson, and F. Schroeder Liver fatty acid binding protein expression in transfected fibroblasts stimulates fatty acid uptake and metabolism Biochim. Biophys. Acta 1301 1996 191 198
108. D.R. Prows, E.J. Murphy, and F. Schroeder Intestinal and liver fatty acid binding proteins differentially affect fatty acid uptake and esterification in L-Cells Lipids 30 1995 907 910
109. E.J. Murphy L-FABP and I-FABP expression increase NBD-stearate uptake and cytoplasmic diffusion in L-cells Am. J. Physiol. 275 1998 G244 G249